Skip to main content
Figure 1 | Journal of Experimental & Clinical Cancer Research

Figure 1

From: Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy

Figure 1

Survival analysis of ovarian cancer-related SNPs. A. overall survival and risk of death for TP53 p.Arg72Pro; B. overall survival and risk of death for PGR p.Val660Leu; C. progression-free survival and cumulative risk of progression for unfavorable PFS factors (ATM p.Asp1853Asn GG genotype and ABCB1 p.Ser893Ala/Trp TT + TA genotypes group).

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us